Chevy Chase Trust Holdings, Inc. United Therapeutics Corp Transaction History
Chevy Chase Trust Holdings, Inc.
- $32.3 Billion
- Q4 2024
A detailed history of Chevy Chase Trust Holdings, Inc. transactions in United Therapeutics Corp stock. As of the latest transaction made, Chevy Chase Trust Holdings, Inc. holds 22,726 shares of UTHR stock, worth $7.98 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
22,726
Previous 23,049
1.4%
Holding current value
$7.98 Million
Previous $8.26 Million
2.92%
% of portfolio
0.02%
Previous 0.03%
Shares
5 transactions
Others Institutions Holding UTHR
# of Institutions
681Shares Held
42.2MCall Options Held
194KPut Options Held
298K-
Black Rock Inc. New York, NY5.47MShares$1.92 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.41MShares$1.55 Billion0.03% of portfolio
-
Wellington Management Group LLP Boston, MA3.17MShares$1.11 Billion0.2% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.86MShares$1 Billion15.42% of portfolio
-
State Street Corp Boston, MA2.24MShares$786 Million0.03% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $16B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...